Patients coping with mesothelioma experienced higher levels of toxicity on CheckMate743 regimen than reported in trials
by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainBased on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of
Updated on: April 10,2024
16

Patients coping with mesothelioma experienced higher levels of toxicity on CheckMate743 regimen than reported in trials
by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainBased on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of
Updated on:April 10,2024
16
